VEROVACCiNES GmbH

VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industrys need for - cost effective vaccines - reduce immunization effort - reduced use of antibiotics A recent development allows to combine several antigens (immunity generating substances) in an single vaccine without increasing production costs. This allows e.g. to target different pathogens with a single vaccine or to generate broad band vaccines targeting immunity evading variants of the same pathogen. The company has a pipeline of 5 vaccine programs at various developmental stages. Four of these...

Multivalent vaccines,subunit marker vaccines,positive safety profile,cost effective manufacturing,combination vaccine,thermostability,and diva

Verovaccines gmbh operates in the Pharmaceutical manufacturing industry.

Verovaccines gmbh's revenue is 11m - 100m

Verovaccines gmbh has 11 - 50 employees.